Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Centro Diagnostico Italiano is a Milan-based healthcare company and outpatient diagnostic and treatment network that operates radiotherapy and radiosurgery services including the CyberKnife Center. The requested name appears to refer to a service line within CDI rather than a separate legal entity. CDI provides stereotactic radiosurgery and radiotherapy for oncology and selected non-oncologic conditions, using CyberKnife systems for highly precise, non-invasive treatment. Its CyberKnife program is used for tumors of the lung, liver, pancreas, prostate, brain and spine, as well as conditions such as trigeminal neuralgia and ocular melanoma. CDI reports long-standing activity in CyberKnife treatment and serves patients through Italy's national health system as well as private channels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cyberknife Center of CDI.